FOR BHARAT BHUSHAN Mehta, an avid tennis and badminton player even at 79, disaster struck during a tennis match about two years ago when the Covid-19 pandemic was on the wane. Attempting a smash, he sprained his shoulder badly. Mehta, who lived for the thrill of the game, tried to ignore the injury, popping pills and consulting some neighbourhood doctors. Nothing eased the pain, but he was not queuing up at hospitals.
Finally, in February 2022, when hospitals had reduced the number of Covid-19 beds and opened their doors to general patients, Mehta consulted a specialist. The diagnosis: Rotator cuff tear. Mehta was soon in hospital for arthroscopic repair surgery and recovered.
Mehta and others like him, who began getting back into physically active life with a vengeance after months of Covid-19 lockdowns and physical distancing, are unwittingly contributing to double-digit growth in sales of pain medications, analgesics, muscle relaxants, over-the-counter (OTC) drugs, and even implants.
Dr Deepak Chaudhary, Senior Director and Head of the Department, Arthroscopy and Sports Medicine at New Delhi’s BLK-Max Super Speciality Hospital, who operated on Mehta, says even minor trauma can cause such muscle tears. The rotator cuff is a group of four muscles on each shoulder joint.
“As individuals age, these muscles can weaken due to wear and tear, and even minor or no trauma can cause tears. Many patients with shoulder pain fail to recognise the seriousness of their condition and resort to self-medication,” says Chaudhary.
It’s not just people getting back to an active life. Many have started lifting weights at home or taking up sports to get fit. Then many had to postpone elective surgeries because hospitals were focussed on the pandemic and were careful about admitting general cases.
هذه القصة مأخوذة من طبعة August 20, 2023 من Business Today India.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة August 20, 2023 من Business Today India.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
"Focus on the challenge of each customer"
SHASHANK KUMAR MD & CO-FOUNDER I RAZORPAY Razorpay is India's first full-stack financial solutions company
PEDAL ON THE FUTURE
THE MG WINDSOR EV, WITH ITS FUTURISTIC AND MINIMALIST DESIGN, COMBINES THE BEST OF BOTH WORLDS-COMFORT AND TECHNOLOGY
BREATHE EASY
Whether you're battling allergies, looking to remove pollutants, or simply want to breathe easier, the right air purifier can make a difference
The Taste of India in a Glass
FROM ROYAL LIQUEURS TO DISTILLED MAHUA, INDIAN HERITAGE ALCOHOLIC BEVERAGES ARE HAVING THEIR DAY IN THE SUN
LOOK BEFORE YOU LEAP
IN 2025, INVESTORS WILL NEED TO FACTOR IN VOLATILITY ACROSS ASSET CLASSES
MISSING ADVISORS
INDIA HAS JUST ONE INVESTMENT ADVISOR FOR NEARLY EVERY 200,000 INVESTORS. AT A TIME WHEN RETAIL PARTICIPATION IN THE STOCK MARKETS IS BOOMING, THIS ASSUMES SIGNIFICANCE
TURNING A CORNER
SHARED ELECTRIC MOBILITY START-UP YULU'S SHIFT TO SERVICING THE QUICK COMMERCE SECTOR IS HELPING IT GROW FAST. IT IS NOW FOCUSSING ON IMPROVING ROAD SAFETY FEATURES AS IT TURNS EBITDA POSITIVE
REALITY CHECK
INDIAN STOCK MARKETS PLUNGED BEGINNING OCTOBER FOR A HOST OF REASONS, INCLUDING A FALL IN FII OWNERSHIP. HOW DEEP WILL THE CORRECTION BE?
TRUMP'S TRADE TANGO
The return of Donald Trump as the 47th President of the US has put the global economy on edge. India, too, is unlikely to remain unaffected. How will policymakers meet this latest challenge?
"The essence of the Trump administration will be transactional”
Global investor, analyst, and best-selling author Ruchir Sharma decodes why Donald Trump won the elections, what India should do, the risks, and more